Literature DB >> 27540881

REVISITING THE USE OF PIOGLITAZONE IN THE TREATMENT OF TYPE 2 DIABETES.

Daniel Einhorn, Vivian Fonseca.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27540881     DOI: 10.4158/EP161409.CO

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


× No keyword cloud information.
  1 in total

1.  Pioglitazone versus sulfonylureas: cardiovascular outcomes with older diabetes drugs.

Authors:  Vivian A Fonseca; Dragana Lovre
Journal:  Lancet Diabetes Endocrinol       Date:  2017-09-13       Impact factor: 32.069

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.